Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial
SE Nissen, EM Tuzcu, P Schoenhagen, BG Brown… - Jama, 2004 - jamanetwork.com
ContextStatin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and
mortality. However, the optimal strategy and target level for lipid reduction remain uncertain …
mortality. However, the optimal strategy and target level for lipid reduction remain uncertain …
[引用][C] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. a randomized controlled trial
SE Nissen, EM Tuzcu… - ACC Current Journal …, 2004 - infona.pl
Effect of intensive compared with moderate lipid-lowering therapy on progression of
coronary atherosclerosis. a randomized controlled trial × Close The Infona portal uses …
coronary atherosclerosis. a randomized controlled trial × Close The Infona portal uses …
[PDF][PDF] Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
JAMA, 2004 - Citeseer
Objective To compare the effect of regimens designed to produce intensive lipid lowering or
moderate lipid lowering on coronary artery atheroma burden and progression. Design …
moderate lipid lowering on coronary artery atheroma burden and progression. Design …
[引用][C] EFFECT OF INTENSIVE COMPARED WITH MODERATE LIPID-LOWERING THERAPY ON PROGRESSION OF CORONARY ATHEROSCLEROSIS: A …
S NISSEN, E TUZCU, P SCHOENHAGEN - 2004 - sid.ir
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial
SE Nissen, EM Tuzcu, P Schoenhagen, BG Brown - JAMA, 2004 - elibrary.ru
Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and
mortality, but the optimal strategy and target level for lipid reduction remain uncertain …
mortality, but the optimal strategy and target level for lipid reduction remain uncertain …
[引用][C] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary Atherosclerosis a randomized controlled trial
SE NISSEN, EM TUZCU, CL GRINES… - JAMA, the journal of …, 2004 - pascal-francis.inist.fr
Effect of intensive compared with moderate lipid-lowering therapy on progression of
coronary Atherosclerosis a randomized controlled trial CNRS Inist Pascal-Francis CNRS …
coronary Atherosclerosis a randomized controlled trial CNRS Inist Pascal-Francis CNRS …
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
SE Nissen, EM Tuzcu, P Schoenhagen, BG Brown… - JAMA, 2004 - europepmc.org
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary
atherosclerosis: a randomized controlled trial. - Abstract - Europe PMC Sign in | Create an …
atherosclerosis: a randomized controlled trial. - Abstract - Europe PMC Sign in | Create an …
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial
SE Nissen, EM Tuzcu, P Schoenhagen, BG Brown… - …, 2004 - pubmed.ncbi.nlm.nih.gov
Context Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and
mortality. However, the optimal strategy and target level for lipid reduction remain uncertain …
mortality. However, the optimal strategy and target level for lipid reduction remain uncertain …
[PDF][PDF] Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
JAMA, 2004 - researchgate.net
Objective To compare the effect of regimens designed to produce intensive lipid lowering or
moderate lipid lowering on coronary artery atheroma burden and progression. Design …
moderate lipid lowering on coronary artery atheroma burden and progression. Design …
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial.
SE Nissen, EM Tuzcu, P Schoenhagen… - JAMA: Journal of …, 2004 - search.ebscohost.com
Context: Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and
mortality. However, the optimal strategy and target level for lipid reduction remain uncertain …
mortality. However, the optimal strategy and target level for lipid reduction remain uncertain …